2022
DOI: 10.1016/j.cyto.2022.156006
|View full text |Cite
|
Sign up to set email alerts
|

Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(19 citation statements)
references
References 90 publications
0
15
0
Order By: Relevance
“…CytoSorb is a widely used HP device for cytokine elimination (<55 kDa) mainly through the size exclusion effect and hydrophobic interactions . However, TNF-α elimination by CytoSorb still remains below 50% because of its low concentration (mostly <1000 ng/L in sepsis) and large size (51 kDa). , Furthermore, the nonspecific adsorbents leading to simultaneous removal of beneficial substances (therapeutic antibiotics, clotting factors, etc.) necessitate additional monitoring of drug levels and adjustments in dosage, causing additional workload for healthcare providers. To enhance the specific removal of TNF-α, Weber et al and Dileo et al constructed immunosorbents with antibodies as high-affinity ligands. , McAlvin et al used antibodies to modify cibdyurs for the elimination of TNF-α from the blood .…”
Section: Introductionmentioning
confidence: 99%
“…CytoSorb is a widely used HP device for cytokine elimination (<55 kDa) mainly through the size exclusion effect and hydrophobic interactions . However, TNF-α elimination by CytoSorb still remains below 50% because of its low concentration (mostly <1000 ng/L in sepsis) and large size (51 kDa). , Furthermore, the nonspecific adsorbents leading to simultaneous removal of beneficial substances (therapeutic antibiotics, clotting factors, etc.) necessitate additional monitoring of drug levels and adjustments in dosage, causing additional workload for healthcare providers. To enhance the specific removal of TNF-α, Weber et al and Dileo et al constructed immunosorbents with antibodies as high-affinity ligands. , McAlvin et al used antibodies to modify cibdyurs for the elimination of TNF-α from the blood .…”
Section: Introductionmentioning
confidence: 99%
“…The damaged cells can promote the inflammatory response as endogenous inflammatory inducers. In addition, M1 macrophages also release excessive proinflammatory cytokines, such as IL-1, IL-8, TNF-α, and IFN-γ ( Gharamti et al, 2022 ). Furthermore, dendritic cells (DCs) can activate toll-like receptors (TLRs) and generate excessive pro-inflammatory factors, which augment the immune response.…”
Section: Introductionmentioning
confidence: 99%
“…Other acute phase reactants such as interleukin-1 beta, tumor necrosis factor-alpha, procalcitonin, and interferon gamma can also act as inflammatory biomarkers. [31][32][33][34][35][36] However, CRP testing is very accessible, relatively inexpensive, and well-established in low-resource clinical settings, 19,22,23,[25][26][27]29,30 making it an ideal choice for combination with qSOFA, a rapid and simple bedside scoring system. 3,37 Current evidence evaluating the performance of a combined qSOFA and CRP score is limited.…”
Section: Introductionmentioning
confidence: 99%
“…Including CRP in qSOFA may improve qSOFA's sensitivity and ability to identify patients at high‐risk of mortality or sepsis. Other acute phase reactants such as interleukin‐1 beta, tumor necrosis factor‐alpha, procalcitonin, and interferon gamma can also act as inflammatory biomarkers 31–36 . However, CRP testing is very accessible, relatively inexpensive, and well‐established in low‐resource clinical settings, 19,22,23,25–27,29,30 making it an ideal choice for combination with qSOFA, a rapid and simple bedside scoring system 3,37 …”
Section: Introductionmentioning
confidence: 99%